Botulinum Toxin Therapy: A Series of Clinical Studies on Patients with Spasmodic Dysphonia in Japan [PDF]
Toxins, 2021 Spasmodic dysphonia (SD) is a rare voice disorder caused by involuntary and intermittent spasms of the laryngeal muscles. Both diagnosis and treatment have been controversial.
Masamitsu Hyodo +6 more
doaj +2 more sources
Retrospective review of dosing trends in botulinum toxin injections for the treatment of adductor spasmodic dysphonia in a long-term cohort [PDF]
Journal of Otolaryngology - Head and Neck Surgery, 2020 Background Botulinum toxin A (BT) is the gold standard treatment for adductor spasmodic dysphonia (AdSD) with established use for greater than thirty years.
Gabrielle French +2 more
doaj +2 more sources
Auditory Feedback Control Mechanisms Do Not Contribute to Cortical Hyperactivity Within the Voice Production Network in Adductor Spasmodic Dysphonia. [PDF]
J Speech Lang Hear Res, 2020 Adductor spasmodic dysphonia (ADSD), the most common form of spasmodic dysphonia, is a debilitating voice disorder characterized by hyperactivity and muscle spasms in the vocal folds during speech.
Daliri A +7 more
europepmc +2 more sources
Validity of intraoperative voice monitoring undergoing type 2 thyroplasty with titanium bridges for adductor spasmodic dysphonia [PDF]
Laryngoscope Investigative Otolaryngology, 2022 Objectives The success of type 2 thyroplasty (TP2) for adductor spasmodic dysphonia (AdSD) depends on the selection of optimally sized titanium bridges, which requires accurate assessment of intraoperative vocal changes.
Tetsuji Sanuki +5 more
doaj +2 more sources
Transnasal Endoscopic Injection of Botulinum Toxin in Patients with Adductor Spasmodic Dysphonia [PDF]
Iranian Journal of OtorhinolaryngologyIntroduction:Adductor Spasmodic Dysphonia (ADSD) is the most common form of spasmodic dysphonia. It encompasses various symptoms affecting voice and speech.
Abdul-Latif Hamdan +3 more
doaj +2 more sources
Anxiety and depression in spasmodic dysphonia patients. [PDF]
World J Otorhinolaryngol Head Neck Surg, 2018 Objective/HypothesisExperts used to believe that spasmodic dysphonia (SD) was a psychogenic disorder. Although SD is now established as a neurological disorder, the rates of co‐morbid anxiety and depression range from 7.1% to 62%. Our objective was to study the prevalence and risk factors associated with these mood disorders in SD patients.Study ...
Hu A, Hillel A, Zhao W, Meyer T.
europepmc +4 more sources
Transcranial magnetic stimulation and functional magnet resonance imaging evaluation of adductor spasmodic dysphonia during phonation [PDF]
Brain Stimulation, 2020 Background: Reduced intracortical inhibition is a neurophysiologic finding in focal dystonia that suggests a broader problem of impaired cortical excitability within the brain.
Mo Chen +6 more
doaj +2 more sources
Cross-linguistic study of vocal pathology: perceptual features of spasmodic dysphonia in French-speaking subjects [PDF]
, 2003 Clinical characterisation of Spasmodic Dysphonia of the adductor type (SD) in French speakers by Klap and colleagues (1993) appears to differ from that of SD in English. This perceptual analysis aims to describe the phonetic features of French SD.
BRIN M. F. +12 more
core +3 more sources
Laryngeal Manual Therapy: A Preliminary Study to Examine its Treatment Effects in the Management of Muscle Tension Dysphonia [PDF]
Journal of Voice, 2009 The objectives of this study were to determine appropriate acoustic and outcome measures for the evaluation of a method of laryngeal manual therapy (LMT) used in the treatment of patients with muscle tension dysphonia (MTD). The effects of this technique
Shashivadan P Hirani
exaly +2 more sources
Pharyngeal Dystonia Mimicking Spasmodic Dysphonia. [PDF]
J Voice, 2018 The aim of this study was to describe the presentation of pharyngeal dystonia (PD), which can occur as a focal or segmental dystonia with a primarily pharyngeal involvement for the discussion of treatment methods for controlling consequent symptoms. PD is specific to speech-related tasks.A retrospective medical record review of four patients with PD ...
Shi LL +4 more
europepmc +5 more sources